Dr. Carney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Boston, MA 02215Phone+1 617-677-7000Fax+1 617-667-8665
Summary
- I am an attending physician in the Division of Hematology and Hematologic Malignancies at Beth Israel Deaconess Medical Center and an Assistant Professor of Medicine at Harvard Medical School. The focus of my research is cancer-associated thrombosis, particularly anticoagulation management in patients at high risk for hemorrhage.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2013 - 2016
Tufts University School of MedicineClass of 2013
Providence CollegeClass of 2009
Certifications & Licensure
MA State Medical License 2013 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Sickle Cell Trait, Inequity, and the Need for Change.Brian J Carney, Maureen O Achebe, Richard L Haspel
The New England Journal of Medicine. 2024-11-28 - CT guided versus non-image guided bone marrow aspiration and biopsy: Comparison of indications, specimen quality and cost.Yousef Alshumrani, Daniel Droukas, Brian J Carney, Robert Willim, Alexander Brook
Clinical Imaging. 2024-09-01 - 2 citationsRecombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura.Pavan K Bendapudi, Brody H Foy, Sarah B Mueller, Jun Liu, Louis M Feingold
The New England Journal of Medicine. 2024-05-09
Lectures
- Recurrent intracranial hemorrhage and venous thromboembolism following initial intracranial hemorrhage in patients with brain tumors on anticoagulation61st Annual American Society of Hematology Meeting - Orlando, FL - 12/8/2019
- Safety of direct-acting oral anticoagulants vs. enoxaparin in patients with primary and metastatic brain tumors60th Annual American Society of Hematology Meeting - San Diego, CA - 12/2/2018
Press Mentions
Modified-Dose Anticoagulation in Patients with Cancer, VTE, and ThrombocytopeniaDecember 1st, 2021
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
